Report Categories
View AllRecent Articles
View All
Lipocine LPCN Stock Investment Opportunity Trend Weakens 20260418
Avidia AVBC Stock Neutral Rating Steady Decline 20260416
Why Viking VACI financial health is stronger than most think Breakdown Watch 20260507
What is supporting Compass Pref CODIA stock growth CODIA Earnings Compass Pref posts steady 725 dividend payouts
iShares ETHB Stock Losing Momentum Momentum Fading 20260420
Is Lincoln LECO stock continuing its trend Lincoln logs 22 EPS beat on strong welding sales
US Federal Reserve Chair Nomination Impasse Institutional Risks and Market Implications
SiriusXM Holdings SIRI Stock Analysis Falls 149 Watching 2454 20260515
Markets Flat as Tech Gains Offset Energy and Financial Weakness
MuskAltman Trial Reveals Techs Dark Underbelly Key Takeaways for Investors
Haleon plc HLN Q4 2024 Earnings EPS 004 Beats Estimates
Gamehaus GMHS Q1 2026 Earnings EPS 004 In Line with Estimates
Simon SPG Trading at 20121 Key Decision Point 20260514
Michael Saylor on Tokenization A Potential Disruptor to Traditional Banking and Brokerage
Fed Minutes Reveal Policymakers Anticipate Potential Rate Hikes if Inflation Persists Amid Geopolitical Risks
Gujarat Government Partners with Meta to Deliver Certificates via WhatsApp Boosting Digital Governance
Wall Street Holds Steady as Healthcare Rally Offsets Industrials Drag
Trumps AntiWeaponization Fund Faces Opposition from Nearly Half of MAGA Supporters Poll Shows
Charter Communications Enhances Offer for Liberty Broadband in New Buyout Deal
Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss
enVVeno Medical Q3 2025 Earnings Narrower Loss Beats Expectations as Clinical Programs Advance
NGVT Q1 2026 Earnings EPS Surges 45 Above Expectations Stock Edges Lower
PLDT Inc Q1 2026 Earnings EPS Falls Slightly Short Amid Stable Operations
ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs
CYN Q1 2026 Earnings EPS Beats Estimates Despite No Reported Revenue
Veracyte Shares Dip as Biotech Sector Faces Headwinds Key Support Tested
KalVista Pharmaceuticals KALV Holds Steady Near Resistance as Investors Eye Key Catalysts
Bright Minds Biosciences DRUG Edges Higher Amid Consolidation Near Key Support Level
Jiuzi Holdings JZXN Edges Higher as Stock Tests Key Resistance Levels
Nuveen Churchill Direct Lending Corp NCDL Holds Steady Near Resistance Level